About Contact Us Careers

Entropion Treatment Market Size and Forecast, by Type (Congenital, Paralytic), Treatment (Artificial Tears, Skin Tape, Anti-inflammatory Drugs, Surgery), End-user (Specialty Clinics, Hospital) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 3777
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT
Festive Special Offer
$4550 $2450

Entropion Treatment Market Outlook:

Entropion Treatment Market size was valued at USD 507.6 million in 2025 and is expected to reach USD 980.02 million by 2035, expanding at around 6.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of entropion treatment is assessed at USD 538.67 million.

Entropion-Treatment-Market-size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The growth of the market can be attributed to the increasing number of elderly people, entropion is most commonly found in old people of the age 60 and above. According to the World Bank census, the total share of global population aged above 65 years in 2020 was 9.318%, up from 8.223% in 2015, and this share is expected to further increase in the upcoming years. 

In addition to these, factors that are believed to fuel the market growth of entropion treatment include the rise in eye related in the world. Entropion is a condition in which the eyelid folds inwards, and can happen in either eyelid. It can lead to corneal ulcer, retinal infection, and even vision impairment due to corneal damage. According to the data by the World Health Organization (WHO), corneal opacities cause moderate to severe distance vision impairment or loss of vision in over 4.2 million people. Meanwhile, 2.2 billion people suffer from partial or complete blindness globally. The growing awareness regarding optical diseases, and penetration of healthcare services in remote areas worldwide are some of the major factors anticipated to drive the market growth.

Key Entropion Treatment Market Insights Summary:

  • Regional Highlights:

    • By 2035, the North America entropion treatment market is anticipated to command a leading revenue share, fueled by the escalating incidence of age-related entropion and widespread dry eye conditions across the elderly population.
    • The Asia Pacific region is projected to secure the largest market share by 2035, supported by its expanding geriatric base that heightens susceptibility to entropion across major countries in the region.

  • Segment Insights:

    • The surgery segment is projected to account for the largest share by 2035 in the entropion treatment market, propelled by the consistent success rates achieved across various surgical techniques enhancing long-term treatment outcomes.
    • The specialty clinics segment is expected to register a notable share by 2035, strengthened by the growing reliance on expert-driven ophthalmic care requiring specialized diagnostic and treatment infrastructure.

  • Key Growth Trends:

    • Growing Population of Old Adults
    • Rising Success Rate of Entropion Treatment

  • Major Challenges:

    • Complications related to eye surgeries
    • Lack of awareness regarding entropion and its treatment

  • Key Players: Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and Alembic Limited.

Global Entropion Treatment Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 507.6 million
    • 2026 Market Size: USD 538.67 million
    • Projected Market Size: USD 980.02 million by 2035
    • Growth Forecasts: 6.8%

  • Key Regional Dynamics:

    • Largest Region: Asia Pacific (largest share by 2035)
    • Fastest Growing Region: North America
    • Dominating Countries: United States, China, Japan, Germany, United Kingdom
    • Emerging Countries: India, South Korea, Brazil, Mexico, Indonesia

    • Last updated on : 20 November, 2025

Growth Drivers

  • Growing Population of Old-Adults - Entropion often only affects the lower eyelid and is more prevalent in older persons. In research of approximately 25,000 people over the age of 60, approximately 2% of patients had involutional entropion. The prevalence of entropion increased with age.

  • Rising Success Rate of Entropion Treatment -Transverse blepharotomy and marginal rotation is a popular treatment for entropion. Moreover, throughout ten days, the bolster and sutures are in place. For the treatment of upper and lower lid cicatricial entropion, this surgery has an 85% success rate.

  • Increased Use of Contact Lenses - A soft contact lens are used to correct the vision, that is compromised due to entropion affected eye. There are around 140 million contact lens wearers in the world. Out of which, nearly 45 million users are in the United States.

  • Rising Prevalence of Dry Eye Syndrome - Dry eye syndrome is a common symptom of entropion eye, it causes itchiness, dryness, and redness. A greater number of people are impacted by dry eyes and decreased tear production. Between 5 to 50 percent of people worldwide have a dry eye condition.

  • Rising Use of Eye Drops - Doctors prescribe the use of mild eye drops to avoid any irritation and redness in the eye. By 2020, at least 3 million people in the UK will use eye drops and ointments daily. Following this, about 2 million people began using eye drops and ointments less frequently than once per month.

Challenges

  • Complications related to eye surgeries - The majority of patients have brief side effects like edoema and bruising after entropion surgery. The market's growth is anticipated to be hampered by the growing concern over additional negative effects related to entropion surgery.
  • Lack of awareness regarding entropion and its treatment
  • High cost of cosmetic treatment for entropion

Entropion Treatment Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

6.8%

Base Year Market Size (2025)

USD 507.6 million

Forecast Year Market Size (2035)

USD 980.02 million

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Entropion Treatment Market Segmentation:

Treatment Segment Analysis

The global entropion treatment market is segmented and analyzed for demand and supply by treatment into artificial tears, skin tape, anti-inflammatory drugs, surgery, and others. Out of the five types of treatment of entropy, the surgery segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the rising success of the surgery for treating entropion. There are many types of surgery that can be opted for entropion treatment, including lateral tarsal strip, rotational or everting sutures, horizontal lid tightening, modified suture canthoplasty, lower lid retractor reinsertion, and others. After an average follow-up of 13 months, a small case series of 15 patients who received solely tarsal strip treatment demonstrated no recurrence of entropion.

End-user Segment Analysis

The global entropion treatment market is also segmented and analyzed for demand and supply by end-user into specialty clinics, hospital, and others. Amongst these three segments, the specialty clinics segment is expected to garner a significant share. Entropion patients frequently struggle to blink, which can cause irritability, infection, and fatigue of the eyes. An ophthalmologist should be contacted right away if a sudden and noticeable lid droop develops. Patients suffering from entropion requires various treatment, including non-invasive and surgical and it should be conducted in specialty clinics under expert guidance with the ophthalmic diagnostic equipment. In 2022, the United States have nearly 1000 eye surgery clinics. Moreover, there are around 1300 eye specialty clinics in India.

Our in-depth analysis of the global market includes the following segments:

             By Type

  • Congenital

  • Paralytic

  • Others

          By Treatment

  • Artificial Tears

  • Skin Tape

  • Anti-inflammatory Drugs

  • Surgery

  • Others

           By End User

  • Specialty Clinics

  • Hospital

  • Others
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Entropion Treatment Market - Regional Analysis

North American Market Insights

The North America industry is anticipated to hold largest revenue share by 2035. The growth of the market can be attributed majorly to the rising cases of entropion in older adults and higher number of people suffering with dry eye issues. According to the American Academy of Ophthalmology, the prevalence of entropion increases with the age, it increased by around 1% for patients aged 60 to 69, nearly 2% for those aged 70 to 79, and around 8% for those above the age of 80. Moreover, in America, between 16 and 49 million people have dry eyes, which accounts for 15% of the population.

APAC Market Insights

The Asia Pacific entropion treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market in the region is credited to large geriatric population in countries that increase the chances of entropion patients in the region, such as India and China. According to the data by the World Bank, the population above 65 years of age in India crossed 90,719,952 in 2020, while, it crossed 167,808,567 in China. 

Entropion-Treatment-Market-share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Entropion Treatment Market Players:

    • Alembic Limited
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Eli Lilly and Company
    • Bausch & Lomb Incorporated
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Sanofi-aventis Groupe
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Siemens Healthcare GmbH
    • Pfizer Inc.

Recent Developments

  • Bausch & Lomb Incorporated, announced the launch of hydration boost lubricant eye drops and micellar eyelid cleansing wipes, under the brand name BioTrue.

  • Novartis AG to acquire Vedere Bio, in order to expand its portfolio to ophthalmology and opto-genetic gene therapy technology for treating blindness.

 

  • Report ID: 3777
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT
Festive Special Offer
$4550 $2450
  • Explore a preview of key market trends and insights
  • Review sample data tables and segment breakdowns
  • Experience the quality of our visual data representations
  • Evaluate our report structure and research methodology
  • Get a glimpse of competitive landscape analysis
  • Understand how regional forecasts are presented
  • Assess the depth of company profiling and benchmarking
  • Preview how actionable insights can support your strategy

Explore real data and analysis

Download Free Sample Report

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of entropion treatment is assessed at USD 538.67 million.

The global entropion treatment market size was valued at over USD 507.6 million in 2025 and is expected to expand at a CAGR of around 6.8%, surpassing USD 980.02 million revenue by 2035.

North America entropion treatment market is anticipated to command a leading revenue share, fueled by the escalating incidence of age-related entropion and widespread dry eye conditions across the elderly population.

Key players in the market include Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and Alembic Limited.

Entropion Treatment Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Buy Now Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos